Head and neck cancers in paediatric population including recent advances
​​

Neville JF, Akhilesh Kumar Singh, Nitesh Mishra, Janani Anand Kumar, Aswathi Krishnan, Ravina Rajpoot

Institute of Medical Sciences, Banaras Hindu University
​
Hellenic Archives of Oral & Maxillofacial Surgery (2022) 1, 25-33

DOI https://dx.doi.org/10.54936/haoms2312533

  Addressing health issues in paediatric population poses a major challenge to health care providers due to lack of child’s capability in expressing   varied range of symptoms through which they undergo which may be of utmost diagnostic significance, thereby delaying early diagnosis.   Unfortunately, Cancer is  well known to be a common cause for increase in mortality rates in children.  To achieve early diagnosis, careful attention to constellation symptoms portrayed by chid and/or parents suggestive of malignancy may aid in earlier diagnosis.   
     With no disparity between early and late diagnosed cases, treatment modalities such as radio/chemotherapy and surgeries poses risk of recurrence,   short and long term effects due to chemo/ radiation.  To overcome all the aforementioned facts, new  perspectives like targeted immunotherapy and Proton beam therapy proves beneficial and prevents  children from emotional and  physical trauma and primarily, from peer pressure.  Updating with common head and cancers and advances in treatment  may facilitate health care professionals in early diagnosis thereby, preventing disease progression.  This article briefs about commonly occuring head and neck tumors in paediatrics, latest updates, advancements  and an overview of impact of  Global pandemic  on current oncology practices with special concern on outcomes to be faced post pandemic. 


REFERENCES

  1. Tandon S and Rajeev K.  Introduction to pedodontics.  Tandon S.   Textbook of Pedodontics, second ed, Paras, Hyderabad, 2008: 2.
  2. Savary C, Kim A, Lespagnol A, Gandemer V, Pellier I,  Andrieu C,  Pages G,   Galibert MD, Blum Y,  Tayrac MD.  Depicting the genetic architecture of pediatric cancers through an integrative gene network approach.  Scientific reports 2020:  10: 1224.
  3. Brasme JF, Morfouace M, Grill J, Martinot A, Amalberti R, Letouzey CB, Chalumeau M.  Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits.  Oncology 2012: 13: 445 -459.
  4. Carberry AR,   Hanson K, Flannery A, Fischer M, Gehlbach J, Diamond C, Wald ER.  Diagnostic Error in Pediatric Cancer.  Clinical Pediatrics 2017: 1-8.
  5. Pedersen LH, Wahlberg A, Cordt M, Schmiegelow K,   Dalton SO, Larsen HB.  Parent’s perspectives of the pathway to diagnosis of childhood cancer: a matter of diagnostic triage.  BMC Health Services Research 2020: 20: 1-12.
  6. Godzinski J and Brecht IB.     Differential Diagnosis of Head and Neck Tumors.   Schneider DT, Brecht IB, Olson A, Ferrari A, eds:     Rare Tumors in Children and Adolescents, Springer, Berlin, 2012: 129-132.
  7. Arboleda LPA, Mendonça RMH, Lopez EEM, Araujo  ALD, Palmier NR,  Paglioni MP, Fonseca JM,  Hoffmann IL,  Cardinalli IA,  Chaves ALF, Aranda S, Brandao TB,  Lopes MA , Ribeiro ACP,  Troconis CCM,  Silvaa ARS.  Global frequency and distribution of head and neck cancer in pediatrics, a systematic review.  Critical Reviews in Oncology/Hematology 2020: 148: 1-13.
  8. Siegel RL,   Miller KD, Jemal A.  Cancer Statistics, 2020.  Ca Cancer J Clin 2020: 70: 7–30.
  9. Sengupta S, Pal R, Saha S and Bera P.  Spectrum of head and neck cancer in children.  Journal of Indian Association of Pediatric Surgeons 2009: 14(4): 200–03.
  10. Rajendran R.  Bengin and malignant tumors of the oral cavity.  Rajendran R   and Sivpathasundharm B.  Textbook of Oral Pathology, seventh ed, Elsevier, New Delhi,  2012: 81-222.
  11. Chadha K and Forte V.  Pediatric Head and Neck Malignancies. Current Opinion in Otolaryngology & Head and Neck Surgery 2009: 17: 471–76.
  12.  Nagpa B, Hegde U, Archana S, Ghosh A, Nagpal A.   Hodgkin’s Lymphoma: A Comprehensive Review for Oral Health Care Practitioners.  International Journal of Health Sciences and Research 2016: 6: 335-343.
  13. Allen CE, Kelly KM, Bollard CM.  Paediatric lymphomas and histiocytic disorders of childhood.  Pediatric Clinics of North America 2015: 62: 139–165.
  14.  Rosolen A, Perkins SL,   Pinkerton CS, Guillerman RP, Sandlund JT, Patte C, Reiter A, Cairo MS.  Revised International Pediatric Non-Hodgkin Lymphoma Staging System.  Journal of Clinical Oncology 2015: 1-9.
  15.  Morgenstern DA, Galindo CR,   Gaze MN.  Imaging in Pediatric Oncology: New Advances and Techniques.  Voss, Stephan D, McHugh, Kieran, eds: Imaging in Pediatric Oncology, Springer, Switzerland, 2019: 1-7. 
  16. Khan AAC and Cheson BD.  Lenalidomide for the Treatment of B-Cell Malignancies.  Journal of Clinical Oncology 2008: 26: 1554-1552.
  17. Olsen EA,   Kim YH,   Kuzel TM, Pacheco TR, Foss FM, Parker S, Frankel SR, Chen C, Ricker RJ, Arduino JM, Duvic M.  Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma.  Journal of clinical oncology 2007: 25: 3109-3115.  
  18. Saletta F,   Seng MS,   Lau LMS.  Advances in paediatric cancer treatment.  Translational Pediatrics 2014: 3: 156-182.
  19. Neville BW, Damm DD, Allen CM and Angela C.  Hematologic disorders.  Neville BW, Damm DD, Allen CM and Angela C.  Oral and maxillofacial pathology, Fourth ed, Elsevier, St. Louis, 2016: 533-571.
  20. Merryman RW and Case AL.  Novel agents and immune invasion in Hodgkin lymphoma.  Hematology 2019: 243-248.
  21. Dumaswala K and   Mehta A.  Novel agents for the treatment of Hodgkin lymphoma.  Expert Review of  Hematology 2015: 8: 659–667.
  22. Spinner MA, MD, Advani RH, Connors JM, Azzi J, Diefenbach C.  New Treatment Algorithms in Hodgkin Lymphoma: Too Much or Too little?  American Society of Clinical Oncology 2018: 626-636.
  23. Parham DM and Barr FG.  Classification of Rhabdomyosarcoma and Its Molecular Basis.  Advances in Anatomic Pathology 2013: 20: 387-397.
  24.  Miwa S, Yamamoto N,  Hayashi K, Takeuchi A, Igarashi K, Tsuchiya H.  Recent Advances and Challenges in the Treatment of Rhabdomyosarcoma.  Cancers 2020: 12: 1-18.
  25. Kontny U, Franzen S, Behrends U, Buhrlen M, Christianse H, Delecluse H,  Eble M,  Feuchtinger T, Gademann G, Granzen B, Kratz CP, Lassay L,  Leuschner I, Mottaghy FM,  Schmitt C, Staatz G, Timmermann B, Vorwerk P, Wilop S, Wolff HA, Mertens R.  Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents – Recommendations of the GPOH-NPC Study Group.  Klinische Padiatrie 2016: 228: 105–112.
  26. Schrijvers D and Licitra L.  Head and neck cancer.  Cavalli F, Kaye SB, Hansen HH, Armitge JO, Piccart-Gebhart M. Textbook of medical oncology, Fourth ed, Informa, UK, 2009: 123-140.
  27. Laser L, Lebenthal Y, Segal K, Steinmetz A, Strenov Y, Cohen M, Yaniv I, Gavan MY, Philip M.   Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors.  Journal of  Clinical  Endocrinology and  Metabolism 2016: 101: 1970–1979.
  28. Cordioli MICV, Moraes L, Cury AM and Cerutti JM.   Are we really at the dawn of understanding sporadic paediatric thyroid carcinoma? Society for Endocrinology 2015: 22: 311-324.
  29. Qian ZJ, Jin MC, Meister KD, Megwalu UC.  Pediatric Thyroid Cancer Incidence and Mortality Trends in the United States, 1973-2013.  Journal of American Medical Association Otolaryngology–Head & Neck Surgery 2019: 145: 617-623.
  30.  Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi M, Rachmiel M, Thompson GB, Yamashita S.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.  The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer. Thyroid 2015:  25: 716-759.
  31. Paulson AV, Rudzinski ER, Hawkins DS.  Thyroid Cancer in the Pediatric Population.  Genes 2019: 10: 1-20.
  32. Dombrowskia ND,   Wolter NE, Irace AL, Cunningham MJ, Mack JW, Marcus KJ, Vargas SO, Perez-Atayde AR, Robson CD, Rahbar R.  Mucoepidermoid carcinoma of the head and neck in children.  International Journal of Pediatric Otorhinolaryngology 2019: 120: 93-99.
  33. Peraza A, Gomez R, Beltran J, Amarista FJ.  Mucoepidermoid Carcinoma. An Update and Review of the Literature.  Journal of Stomatology oral and Maxillofacial Surgery 2020: 1-38.
  34. Grobner SN, Worst BC,  Weischenfeldt J,  Buchhalter I, Kleinheinz K, Rudneva VA,    Johann PD,   Balasubramanian GP,   Segura-Wang M,  Brabetz S,  Bender S,   Hutter B,  Sturm D,  Pfaff E,  Hubschmann D,  Zipprich G,   Heinold M,  Eils J, Lawerenz C,  Erkek S,  Lambo S,  Waszak S,  Blattmann C,   Borkhardt A,  Kuhlen M,  Eggert A,  Fulda S,   Gessler M, Wegert J,  Kappler R,   Baumhoer D,  Burdach S,  Kirschner-Schwabe R,  Kontny U,  Kulozik AE,  Lohmann D,  Hettmer S, Eckert C,  Bielack S,   Nathrath M, Niemeyer C,  Richter GH,  Schulte J,  Siebert R,  Westermann F,   Molenaar JJ,  Vassal G,  Witt H,  ICGC PedBrain-Seq Project, ICGC mmmL-Seq Project,    Burkhardt B,   Kratz CP,  Witt O,    van Tilburg CM,   Kramm M,   Fleischhack G,  Dirksen U, Rutkowski S,   Frühwald M,  von hoff K,  Wolf S,   Klingebiel T,   Koscielniak E,  Landgraf P,   Koster J, Resnick AC,  Zhang J,  Liu Y,   Zhou X,   Waanders AJ,   Zwijnenburg DA,   Raman P,  Brors B,   Weber UD,    Northcott PA,   Pajtler KW,   Kool M,    Piro RM,   Korbel JO,  Schlesner M,   Eils R,  Jones DTW,  Lichter P,  Chavez L,  Zapatka M,   Pfister SM.  The landscape of genomic alterations across childhood cancers.  Nature 2018: 555: 321-27.
  35. Weber DC, Habrand JL, Hoppe BS, Kayser CH, Laack NN, Langendijk JA, MacDonald SM, McGovern SL, Pater L, Perentesis JP, Thariat J, Timmerman B, Yock TI, Mahajan A.  Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN.  Radiotherapy and Oncology 2018: 1-12.
  36. Greenberger BA and Yock TI.  The role of proton therapy in pediatric malignancies: Recent advances and future directions.  Seminars in Oncology 2020: 47: 8-22.
  37. Stephens FO and   Aigner KR.  Future Directions.  Mersh TA, Hortobagyi G, Khayat D, Picksley SM, Sugarbaker P, Tagushi T, Thompson J.  Basics of Oncology, Springer, Berlin, Second Ed, 2009: 315-328.
  38. Shankar A, Saini D, Richa, Goyal N, Roy S, Angural H, Kaushal V, Bharati SJ, Upadhaya R, Durga T.  Cancer Care Delivery Challenges in India during the COVID‑19 Era: Are We Prepared for the Postpandemic Shock?  Asian Pacific Journal of Oncology and Nursing 2021: 8: 1‑4.
  39.  Vasquez L, Sampor C, Villanueva G, Maradiegue E, Lombardi MG, Gomez-Garcia W, Moreno F, Diaz R, Capellano AM, Portilla CA, Salas B, Nava E, Brizuela S,  Jimenez S,  Espinoza X,   Gassant PY,  Quintero K,  Fuentes-Alabi S, Velasquez T,  Fu L,  Gamboa Y,  Quintana J,  Castiglioni M,  Nunez C,  Moreno A,  Fineman SL,  Luciani S,   Chantada G. Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America. Oncology 2020: 21: 753-54.
  40. Kutluk MT, Ahmed F, Kirazli M, Bajin IY, Mungen E, Ekinci S, Yildiz F.  The effect of the COVID-19 pandemic on paediatric cancer care: lessons learnt from a major paediatric oncology department in Turkey.  ecancer 2021: 15: 1-16.
How to cite this article:
View the full-text PDF:
gnatho_vol23_n1_2022_lr-31-39.pdf
File Size: 180 kb
File Type: pdf
Download File
Triannual medical Journal - The official publication of the Hellenic Association for Oral and Maxillofacial Surgery. ISSN 1108-829​X, ISSN (electronic) 2241-5939
Hellenic Archives of Oral and Maxillofacial Surgery (HAOMS Journal) © 2021 by Hellenic Association for Oral & Maxillofacial Surgery on behalf of HAOMS Journal's Authors is licensed under Attribution-NonCommercial 4.0 International. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc/4.0/